The Australian Pesticides and Veterinary Medicine Authority (APVMA) have released the final decisions from the review of macrolide antibiotics kitasamycin, oleandomycin and tylosin. These regulatory decisions include more robust label instructions to ensure prudent antibiotic use in pigs, registration cancellations and additional label statements encouraging users to investigate non-antibiotic treatment options. Full details of the regulatory decisions are outlined in the macrolide antibiotics regulatory decisions report, which was published on 6 April 2018. This review was initiated due to concerns about antibiotic resistance and the potential risks to human health from the transfer of antibiotic resistance from animals to humans. The regulatory decisions outlined in the report will reduce the over-prescription of antibiotics, a major cause of antimicrobial resistance. More information about the review is available on the macrolide antibiotics chemical review page of our website.
APVMA Regulatory Update, 11 April 2018 ; http://www.apvma.gov.au